2008
DOI: 10.1196/annals.1413.004
|View full text |Cite
|
Sign up to set email alerts
|

Lymphatic Tissue Engineering

Abstract: In the last 5 years major advances have been made in the field of tissue engineering. However, while engineering of tissues from nearly every major system in the body have been studied and improved, little has been done with the engineering of viable lymphatic tissues. Recent advances in understanding of lymphatic biology have allowed the easy isolation of pure lymphatic cell cultures, increasing, in turn, the ability to study lymphatic biology in greater detail. This has allowed the elucidation of lymphatic p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 30 publications
0
16
0
Order By: Relevance
“…Our model also utilises more aspects of the entire lymphatic drainage (e.g. the regular deformations of the surrounding matrix to lymphatic capillaries) than previous models of the primary lymphatic valve system [13,18,21,38,42].…”
Section: Discussionmentioning
confidence: 99%
“…Our model also utilises more aspects of the entire lymphatic drainage (e.g. the regular deformations of the surrounding matrix to lymphatic capillaries) than previous models of the primary lymphatic valve system [13,18,21,38,42].…”
Section: Discussionmentioning
confidence: 99%
“…The LECs embryologically originate from out pouching of blood endothelial cells from cardinal vein, and they both share close structural similarities. About 300 genes are expressed differentially between blood endothelial cells and LECs, which includes LEC-specific genes (lymphatic vessel hyaluronan receptor 1, vascular endothelial growth factor receptor 3, prox1, podoplanin, and Ī²-chemokine receptor D6), integrins, cadherins, proinflammatory cytokines, and chemokines [9]. …”
Section: Tissue Engineering Of Lymphatic Graftmentioning
confidence: 99%
“…Engineered three-dimensional (3D) microvascular networks are also expected to find widespread clinical use as a treatment to reverse tissue ischemia caused by disease or injury (Hitchcock and Niklason, 2008). In addition, there is a broad need for a variety of vascularized 3D models of physiological systems that can better predict efficacy, safety, bioavailability and toxicology outcomes for candidate therapeutics (Lin and Chang, 2008).…”
Section: Introductionmentioning
confidence: 99%